CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Different pCR rates according PAM50 defined subtypes in HER2 positive early breast cancer treated with neoadjuvant pertuzumab and trastuzumab.
Author
Aleix Prat
Alejandro Falcon
+18 more
Aranzazu Fernández
Aurora Laborda Illanez
Begona Jimenez Rodriguez
Cristina Morales-Estevez
Emilio Alba
Fernando Galvez Montosa
Javier Pascual
Jose Manuel Jerez
Luis Vicioso
Macarena González Guerrero
Maria Carmen Álamo de la Gala
Marta Amerigo Góngora
Martina Álvarez
Nuria Chic
Nuria Ribelles
Rocío Lavado-Valenzuela
Tamara Diaz-Redondo
Tomás Pascual
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref